Title : SLURP-1, an endogenous alpha7 nicotinic acetylcholine receptor allosteric ligand, is expressed in CD205(+) dendritic cells in human tonsils and potentiates lymphocytic cholinergic activity - Fujii_2014_J.Neuroimmunol_267_43 |
Author(s) : Fujii T , Horiguchi K , Sunaga H , Moriwaki Y , Misawa H , Kasahara T , Tsuji S , Kawashima K |
Ref : Journal of Neuroimmunology , 267 :43 , 2014 |
Abstract :
Immune cells often express various nicotinic ACh receptor (nAChR) subtypes, including alpha7 nAChRs, as well as mRNA encoding secreted lymphocyte antigen-6/urokinase-type plasminogen activator receptor-related peptide (SLURP)-1, an endogenous alpha7 nAChR allosteric ligand. We detected SLURP-1 immunoreactivity in CD205(+) dendritic cells (DCs) residing in human tonsils. Phytohemagglutinin (PHA, 10mug/ml), a T cell activator, attenuated cell proliferation and increased the ACh content of MOLT-3 human leukemic T cells compared with the vehicle control. Methyllycaconitine (MLA, 100nM), a specific alpha7 nAChR antagonist, abolished all effects elicited by PHA. Recombinant (r)SLURP-1 (0.5mug/ml) attenuated peripheral blood mononuclear cell proliferation and increased ChAT gene expression and the ACh content in MOLT-3 cells compared with the control, all of which were abolished by MLA. This suggests SLURP-1 activates cholinergic transmission by potentiating ACh synthesis and its action at alpha7 nAChRs, thereby facilitating functional development of T cells. These findings support the notion that SLURP-1 acts as a key modulator of immune responses. |
PubMedSearch : Fujii_2014_J.Neuroimmunol_267_43 |
PubMedID: 24365495 |
Fujii T, Horiguchi K, Sunaga H, Moriwaki Y, Misawa H, Kasahara T, Tsuji S, Kawashima K (2014)
SLURP-1, an endogenous alpha7 nicotinic acetylcholine receptor allosteric ligand, is expressed in CD205(+) dendritic cells in human tonsils and potentiates lymphocytic cholinergic activity
Journal of Neuroimmunology
267 :43
Fujii T, Horiguchi K, Sunaga H, Moriwaki Y, Misawa H, Kasahara T, Tsuji S, Kawashima K (2014)
Journal of Neuroimmunology
267 :43